Specialized Niches for Pediatric Astrocytoma Cells
儿童星形细胞瘤细胞的专门利基
基本信息
- 批准号:8044511
- 负责人:
- 金额:$ 35.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-02-16 至 2016-01-31
- 项目状态:已结题
- 来源:
- 关键词:Adenylate CyclaseAntibodiesAreaAstrocytomaBRAF geneBiological AssayBrainBrain StemBrain regionCell SurvivalCellsCerebellar AstrocytomaCerebellar Pilocytic AstrocytomaCerebellumCharacteristicsChildChildhood Astrocytic TumorChildhood Brain NeoplasmCiliaEnvironmentEventExhibitsFutureGrowthHumanInstructionLocationMaintenanceMutationOncogenicOrganellesPathologyPathway interactionsPatientsProsencephalonSamplingSignal TransductionSliceSpecificitySpecimenTherapeuticTreatment EfficacyTubulinXenograft procedurebasehindbraininnovationmigrationneoplastic cellnerve stem cellnew therapeutic targetnovel therapeutic interventionoverexpressionresponsetumortumor growth
项目摘要
The overall objective ofthis project is to develop a new understanding ofthe microenvironment that supports
the growth, survival and migration of astrocytoma cells, and thereby identify new therapeutic approaches. In
preliminary studies we have shown that human astrocytoma cells do not grow indiscriminately within the
brain parenchyma, but prefer to grow in particular microenvironments. In the proposed studies we will use
primary cultures from patient samples to determine whether astrocytomas are addicted to the environment of
the brain region in which they developed, and to define cellular mechanisms by which the tumor
microenvironment promotes tumor maintenance. We have three aims:
Aim One: Determine whether pediatric astrocytomas are "addicted" to the particular location in
which they originated. We will use a new slice overiay assay, to determine whether i) forebrain tumors
preferenfially grow in the specialized microenvironment of the forebrain; ii) hindbrain tumors preferentially
grow in the cerebellum and brainstem areas ofthe hindbrain; iii) BRAF overexpression, a characteristic
feature of cerebellar pilocytic astrocytomas, specifically facilitates growth of neural precursor in the cerebellar
microenvironment.
Aim Two: Define the cellular basis ofthe microenvironment While the microenvironment is cleariy
important for tumor growth and maintenance, the reason why tumor cells are preferentially found in particular
locations is not understood. We will determine whether i) the microenvironment stimulates tumor
proliferafion; ii) the microenvironment selectively promotes tumor cell survival; iii) tumor cells preferentially
migrate towards this microenvironment.
Aim Three: Determine whether primary cilia coordinate the tumor cell response to its
microenvironment. Our preliminary studies indicate that many astrocytoma samples exhibit primary cilia,
visualized with antibodies to acetylated tubulin or adenylate cyclase 3. To determine whether primary cilia
are signaling organelles that contribute to growth of astrocytomas, we will determine whether i) Primary cilia
are preferenfially found on higher grade tumors; ii) Primary cilia point towards the vasculature; iii)
components of crifical growth pathways localized to cilia of tumor cells; iv) Primary cilia are required for
tumor growth.
RELEVANCE (See instructions):
In cooperation with the Innovative Neuro Pathology (INP) Core and Projects One and Two, these studies
on the tumor microenvironment will identify new therapeutic targets for treating pediatric brain tumors. Future
therapies can then be developed that attack the interactions of the tumor and its microenvironment, an
approach that may allow therapeutic efficacy with less damage to the normally developing brains of children.
J
PROJECT/
本项目的总体目标是对微环境有一个新的理解,
星形细胞瘤细胞的生长、存活和迁移,从而确定新的治疗方法。在
我们的初步研究表明,人星形细胞瘤细胞不会在肿瘤细胞内不加选择地生长,
脑实质,但更喜欢在特定的微环境中生长。在拟议的研究中,我们将使用
从患者样本中进行原代培养,以确定星形细胞瘤是否依赖于
他们发展的大脑区域,并确定肿瘤发生的细胞机制。
微环境促进肿瘤维持。我们有三个目标:
目的一:确定儿童星形细胞瘤是否对肿瘤的特定部位“上瘾”。
他们所创造的。我们将使用一种新的切片检测方法来确定i)前脑肿瘤
优先生长在前脑的特殊微环境中; ii)后脑肿瘤优先
生长在小脑和脑干区域的后脑; iii)BRAF过表达,一个特征性的
小脑毛细胞星形细胞瘤的特征,特别是促进小脑神经前体细胞的生长
微环境
目的二:明确微环境的细胞基础
对于肿瘤的生长和维持很重要,肿瘤细胞被优先发现的原因特别是
位置不了解。我们将确定i)微环境是否刺激肿瘤
ii)微环境选择性地促进肿瘤细胞存活; iii)肿瘤细胞优先地
向这个微环境迁移。
目的三:确定初级纤毛是否协调肿瘤细胞对其纤毛的反应。
微环境我们的初步研究表明,许多星形细胞瘤样本显示初级纤毛,
用乙酰化微管蛋白或腺苷酸环化酶3的抗体显示。为了确定初级纤毛
是有助于星形细胞瘤生长的信号细胞器,我们将确定i)初级纤毛
优先发现于更高级别的肿瘤; ii)初级纤毛指向脉管系统; iii)
关键生长途径的成分定位于肿瘤细胞的纤毛; iv)初级纤毛是肿瘤细胞生长所必需的。
肿瘤生长
相关性(参见说明):
与创新神经病理学(INP)核心和项目一和二合作,这些研究
肿瘤微环境的研究将确定治疗小儿脑肿瘤的新靶点。未来
然后可以开发出攻击肿瘤及其微环境相互作用的疗法,
这种方法可以在对儿童正常发育的大脑损伤较小的情况下实现治疗效果。
J
项目/
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROSALIND A. SEGAL其他文献
ROSALIND A. SEGAL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROSALIND A. SEGAL', 18)}}的其他基金
Formation and function of pathologic stress granules containing RNA-Binding Protein SFPQ in tauopathy
tau蛋白病中含有RNA结合蛋白SFPQ的病理应激颗粒的形成和功能
- 批准号:
10581946 - 财政年份:2023
- 资助金额:
$ 35.79万 - 项目类别:
(PQ9) The role of Bclw (bcl2l2) in preventing chemotherapy induced neuropathy
(PQ9) Bclw (bcl2l2) 在预防化疗引起的神经病变中的作用
- 批准号:
9251786 - 财政年份:2016
- 资助金额:
$ 35.79万 - 项目类别:
(PQ9) The role of Bclw (bcl2l2) in preventing chemotherapy induced neuropathy
(PQ9) Bclw (bcl2l2) 在预防化疗引起的神经病变中的作用
- 批准号:
9896777 - 财政年份:2016
- 资助金额:
$ 35.79万 - 项目类别:
Axonal transport and chemotherapy induced peripheral neuropathy
轴突运输和化疗引起的周围神经病变
- 批准号:
10649524 - 财政年份:2016
- 资助金额:
$ 35.79万 - 项目类别:
Axonal transport and chemotherapy induced peripheral neuropathy
轴突运输和化疗引起的周围神经病变
- 批准号:
10522882 - 财政年份:2016
- 资助金额:
$ 35.79万 - 项目类别:
Therapeutic Opportunities for Pediatric Astrocytoma
儿童星形细胞瘤的治疗机会
- 批准号:
8019642 - 财政年份:2011
- 资助金额:
$ 35.79万 - 项目类别:
Therapeutic Opportunities for Pediatric Astrocytoma
儿童星形细胞瘤的治疗机会
- 批准号:
8450180 - 财政年份:2011
- 资助金额:
$ 35.79万 - 项目类别:
Therapeutic Opportunities for Pediatric Astrocytoma
儿童星形细胞瘤的治疗机会
- 批准号:
8627572 - 财政年份:2011
- 资助金额:
$ 35.79万 - 项目类别:
Therapeutic Opportunities for Pediatric Astrocytoma
儿童星形细胞瘤的治疗机会
- 批准号:
8230535 - 财政年份:2011
- 资助金额:
$ 35.79万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 35.79万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 35.79万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 35.79万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 35.79万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 35.79万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 35.79万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 35.79万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 35.79万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 35.79万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 35.79万 - 项目类别:














{{item.name}}会员




